Cusbo soodhiyam Cefoxitin CAS:33564-30-6
Cusbada soodhiyamka ee Cefoxitin waxaa qora bixiyeyaasha daryeelka caafimaadka si loogu daaweeyo caabuqyo kala duwan sida caabuqyada caloosha gudaheeda, caabuqyada haweenka, caabuqyada maqaarka iyo unugyada jilicsan, caabuqyada kaadi mareenka, iyo cudurrada bararka miskaha. Kahor inta aan la isticmaalin cusbada soodhiyamka ee cefoxitin, bukaanadu waa inay la tashadaan xirfadle daryeel caafimaad si loo go'aamiyo qiyaasta ku habboon iyo muddada daaweynta iyadoo lagu saleynayo nooca gaarka ah iyo darnaanta caabuqa. Bukaanadu waxay caadi ahaan helaan cusbada soodhiyamka ee cefoxitin iyada oo loo marayo maamul xidid ama xidid dhiig ah iyadoo la kormeerayo caafimaadka si loo hubiyo gaarsiinta saxda ah iyo la socodka jawaabta daaweynta. Waa muhiim in bukaanadu u hoggaansamaan jadwalka qiyaasta loo qoray oo ay dhammaystiraan koorsada daaweynta oo dhan sida loogu talagalay, xitaa haddii calaamadaha ay soo fiicnaadaan ka hor dhammaystirka. In kasta oo cusbada soodhiyamka ee cefoxitin guud ahaan si fiican loo dulqaato, waxyeellooyinka iman kara waxaa ka mid noqon kara khalkhalka caloosha iyo mindhicirka, falcelinta xasaasiyadda, ama caabuqyada ka sarreeya. Bukaannada waa in lala socdaa waxyeellooyinka ka dhasha inta lagu jiro daaweynta, waxyeellooyinka daran ama kuwa joogtada ahna waa in si degdeg ah loogu wargeliyaa bixiye daryeel caafimaad si loo qiimeeyo loona maareeyo. Guud ahaan, cusbada soodhiyamka ee cefoxitin waxay u adeegtaa ikhtiyaar antibiyootiko oo wax ku ool ah oo lagula dagaallamo caabuqyada bakteeriyada marka si habboon loo isticmaalo iyada oo la raacayo hagitaan caafimaad.
| Halabuurka | C16H18N3NaO7S2 |
| Baaritaan | 99% |
| Muuqaalka | budo cad |
| Lambarka CAS. | 33564-30-6 |
| Baakad | Yar iyo weyn |
| Muddada Khafiska | 2 sano |
| Kaydinta | Ku kaydi meel qabow oo qalalan |
| Shahaadada | ISO. |








![2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione CAS:446292-08-6](https://cdn.globalso.com/xindaobiotech/8NS8DBIRAVXN0VCLT215.png)